Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Measures of Central Tendency02:16

Measures of Central Tendency

The "center" of a data set is also a way of describing location. The two most widely used measures of the "center" of the data are the mean (average) and the median. The words "mean" and "average" are often used interchangeably. The substitution of one word for the other is common practice. The technical term is "arithmetic mean" and "average" is technically a center location. However, in practice among non-statisticians, "average" is commonly accepted for "arithmetic mean."
Odds Ratio01:09

Odds Ratio

The odds ratio (OR) is a statistical measure used extensively in epidemiology and research to quantify the strength of association between exposure and outcome across different groups. Unlike relative risk, which compares the probabilities of an event occurring, the odds ratio compares the odds of an event occurring in the exposed group to the odds of it occurring in the unexposed group. The odds, in this context, are calculated as the probability of the event happening divided by the...
Guidelines for Writing Outcome01:11

Guidelines for Writing Outcome

When developing expected outcomes for a patient care plan, the nurse should adhere to the following recommendations:
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care evaluation by...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Measurement: Derived Units03:02

Measurement: Derived Units

The International System of Units or SI system, by international agreement, has fixed measurement units for seven fundamental properties: length, mass, time, temperature, electric current, amount of substance, and luminosity. These are called the SI base units.
Quantifying Work02:30

Quantifying Work

As a system undergoes a change, its internal energy can change, and energy can be transferred from the system to the surroundings, or from the surroundings to the system.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association between <i>IL1B</i> rs16944 polymorphism and the risk of idiopathic inflammatory myopathies.

Frontiers in immunology·2026
Same author

Renal efficacy of calcineurin inhibitors in treatment-resistant lupus nephritis: An experience among Mexican patients from a tertiary referral center.

Lupus·2026
Same author

Factors Associated With Delay in the Diagnosis and Treatment of Systemic Lupus Erythematosus: A Qualitative Study With Mexican Patients and Rheumatologists.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases·2025
Same author

Differential glomerular expression patterns of Th17-related cytokines in Mexican patients with lupus nephritis.

Lupus·2025
Same author

Clinical Practice Mexican Guidelines for the Treatment of Systemic Lupus Erythematosus: 2024 Update.

Reumatologia clinica·2024
Same author

Update of the guidelines for the pharmacological treatment of rheumatoid arthritis by the Mexican College of Rheumatology 2023.

Reumatologia clinica·2024
Same journal

Clinical validation of video DASH for upper limb disorders in rheumatic patients.

Reumatologia clinica·2026
Same journal

Coexistence of systemic lupus erythematosus and sarcoidosis: A case-based review.

Reumatologia clinica·2026
Same journal

Factors associated with the perception of body image in patients with psoriatic disease.

Reumatologia clinica·2026
Same journal

Anti-Mi-2-positive amyopathic dermatomyositis unveiled by a V-sign.

Reumatologia clinica·2026
Same journal

Antinuclear antibody detection beyond anti-dsDNA and anti-ENA: New insights from intact HEp-2 nucleus ELISA.

Reumatologia clinica·2026
Same journal

Long-term stability of autoantibody-based serological profiles in systemic lupus erythematosus.

Reumatologia clinica·2026
See all related articles

Related Experiment Video

Updated: May 30, 2026

Using Learning Outcome Measures to assess Doctoral Nursing Education
10:07

Using Learning Outcome Measures to assess Doctoral Nursing Education

Published on: June 21, 2010

[Outcome measures].

Lilia Andrade-Ortega1

  • 1Servicio de Reumatología, Centro Médico Nacional 20 de Noviembre, ISSSTE, México D. F., México; Universidad Nacional Autónoma de México, México D. F., México. liliaandrade@prodigy.net.mx

Reumatologia Clinica
|July 29, 2011
PubMed
Summary
This summary is machine-generated.

Inflammatory myositis diseases are rare and varied. Standardized outcome measures for disease activity and damage have been developed, enabling more reliable and comparable clinical studies.

More Related Videos

Electroencephalographic, Heart Rate, and Galvanic Skin Response Assessment for an Advertising Perception Study: Application to Antismoking Public Service Announcements
06:39

Electroencephalographic, Heart Rate, and Galvanic Skin Response Assessment for an Advertising Perception Study: Application to Antismoking Public Service Announcements

Published on: August 28, 2017

Related Experiment Videos

Last Updated: May 30, 2026

Using Learning Outcome Measures to assess Doctoral Nursing Education
10:07

Using Learning Outcome Measures to assess Doctoral Nursing Education

Published on: June 21, 2010

Electroencephalographic, Heart Rate, and Galvanic Skin Response Assessment for an Advertising Perception Study: Application to Antismoking Public Service Announcements
06:39

Electroencephalographic, Heart Rate, and Galvanic Skin Response Assessment for an Advertising Perception Study: Application to Antismoking Public Service Announcements

Published on: August 28, 2017

Area of Science:

  • Rheumatology
  • Neurology
  • Immunology

Context:

  • Inflammatory myositis encompasses a group of rare and heterogeneous autoimmune diseases affecting muscles.
  • Clinical and therapeutic studies in this field often face challenges due to varying diagnostic criteria, inclusion criteria, and outcome measures.
  • This heterogeneity can hinder the comparability and reliability of research findings.

Purpose:

  • To address the variability in clinical studies of inflammatory myositis.
  • To introduce and validate standardized outcome measures for assessing disease activity and damage.
  • To facilitate more consistent and comparable research across different studies.

Summary:

  • Recent collaborative efforts have led to the development and validation of core set outcome measures for inflammatory myositis.
  • These measures assess both the activity and the damage associated with these rare muscle diseases.
  • The validated measures aim to standardize the assessment of patients in clinical trials.

Impact:

  • Widespread adoption of these core set measures will lead to more standardized clinical studies.
  • This standardization will improve the reliability of research results in inflammatory myositis.
  • Enables direct comparison of findings between individual studies, advancing therapeutic development.